Category: QUEBEC

Highline Beta invests in Aifred Health to support its mission of improving clinical decision making for mental health

Highline Beta participated in Aifred Health’s recent $4M seed financing, which was co-led by MEDTEQ and BDC Capital, with support from Desjardins Group and other private and institutional investors. The funding will be used to support the North American regulatory approval clinical trial designed to test the safety and effectiveness of Aifred Health’s AI technology to inform personalized therapeutic treatment choice for patients suffering from clinical depression.